| ASSET | DATE | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 7/1/2026 | 31.86% |
Maase (MAAS) | 7/1/2026 | 20.15% |
Oscar Health (OSCR) | 7/1/2026 | 11.15% |
Strive (ASST) | 7/1/2026 | 10.89% |
Twenty One Capital (XXI) | 7/1/2026 | 8.91% |
Webull (BULL) | 7/1/2026 | 8.79% |
MakeMyTrip (MMYT) | 7/1/2026 | 8.66% |
ManpowerGroup (MAN) | 7/1/2026 | 8.66% |
Karman (KRMN) | 7/1/2026 | 8.19% |
John Wiley & Sons B (WLYB) | 7/1/2026 | 8.01% |
Liberty Global PLC Class B (LBTYB) | 7/1/2026 | 7.93% |
McGraw Hill (MH) | 7/1/2026 | 7.92% |
Accelerant (ARX) | 7/1/2026 | 7.81% |
Dlocal (DLO) | 7/1/2026 | 7.79% |
Celsius (CELH) | 7/1/2026 | 7.45% |
Coty (COTY) | 7/1/2026 | 7.04% |
Hims Hers Health (HIMS) | 7/1/2026 | 7.04% |
Marex Group plc Ordinary Shares (MRX) | 7/1/2026 | 7.01% |
Magnite (MGNI) | 7/1/2026 | 6.79% |
Lifestance Health (LFST) | 7/1/2026 | 6.72% |
Figure Technology Solutions, Inc Class A Common Stock (FIGR) | 7/1/2026 | 6.69% |
ELF Beauty (ELF) | 7/1/2026 | 6.68% |
Hyperliquid Strategies Inc Common Stock (PURR) | 7/1/2026 | 6.62% |
Immunitybio (IBRX) | 7/1/2026 | 6.42% |
TriNet (TNET) | 7/1/2026 | 6.4% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.